Prices are updated after-hours
Sort by: after hours % change | delayed % change | gain open | gain high | gain close | publishing date
tags : Phase 2    source : Www.zynerba.com    save search
Zynerba Pharmaceuticals Announces Completion of Enrollment in Phase 2 Trial of Zygel™ in 22q11.2 Deletion Syndrome
Published: 2022-02-28 (Crawled : 13:30) - zynerba.com
ZYNE | $1.3 3.08% 860K twitter stocktwits trandingview |
Health Technology
 | | O: -4.76% H: 0.0% C: 0.0%
phase 2 als trial syndros enroll zygel
Zynerba Pharmaceuticals Announces Publication of Results of Phase 2 BELIEVE Open-Label Study of Zygel™ in Children and Adolescents with Developmental and Epileptic Encephalopathies (DEE) in JAMA Network Open
Published: 2021-09-07 (Crawled : 11:00) - zynerba.com
ZYNE | $1.3 3.08% 860K twitter stocktwits trandingview |
Health Technology
 | | O: -1.11% H: 3.14% C: 0.0%
phase 2 results children zygel
Gainers vs Losers
67% 33%

Top 10 Gainers
RCON | $0.1112 13.01% 21.28% 1.7M twitter stocktwits trandingview |
Distribution Services
GBR | $1.42 31.48% 11.27% 990K twitter stocktwits trandingview |
Energy Minerals
DEO | News | $140.76 -0.02% 8.27% 560K twitter stocktwits trandingview |
Consumer Non-Durables
KUKE | $2.88 2.49% 7.64% 360K twitter stocktwits trandingview |

LYT | $4.22 4.72% 5.62% 1.4M twitter stocktwits trandingview |

SYY | $76.73 1.44% 5.49% 2.5M twitter stocktwits trandingview |
Distribution Services
TWI | $11.53 0.96% 4.94% 330K twitter stocktwits trandingview |
Producer Manufacturing
BTCM | $1.99 -6.13% 4.52% 75K twitter stocktwits trandingview |
Arts, Entertainment, and Recrea...
MPLN | $0.6502 -11.74% 4.51% 2.2M twitter stocktwits trandingview |
Finance
CXM 4 | $11.34 -0.44% 4.27% 1.7M twitter stocktwits trandingview |
Information
Your saved searches
Save your searches and get alerts when important news are released.